ATE10806T1 - Verfahren zur herstellung von hepatitis boberfl[chenantigen. - Google Patents

Verfahren zur herstellung von hepatitis boberfl[chenantigen.

Info

Publication number
ATE10806T1
ATE10806T1 AT80401546T AT80401546T ATE10806T1 AT E10806 T1 ATE10806 T1 AT E10806T1 AT 80401546 T AT80401546 T AT 80401546T AT 80401546 T AT80401546 T AT 80401546T AT E10806 T1 ATE10806 T1 AT E10806T1
Authority
AT
Austria
Prior art keywords
hepatitis
antigen
bosurface
procedure
production
Prior art date
Application number
AT80401546T
Other languages
English (en)
Inventor
William J. Mcaleer
Henry Z. Markus
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Application granted granted Critical
Publication of ATE10806T1 publication Critical patent/ATE10806T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT80401546T 1979-11-02 1980-10-30 Verfahren zur herstellung von hepatitis boberfl[chenantigen. ATE10806T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/090,169 US4301250A (en) 1979-11-02 1979-11-02 Method of producing hepatitis B surface antigen
EP80401546A EP0028567B1 (de) 1979-11-02 1980-10-30 Verfahren zur Herstellung von Hepatitis B-Oberflächenantigen

Publications (1)

Publication Number Publication Date
ATE10806T1 true ATE10806T1 (de) 1985-01-15

Family

ID=22221612

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80401546T ATE10806T1 (de) 1979-11-02 1980-10-30 Verfahren zur herstellung von hepatitis boberfl[chenantigen.

Country Status (10)

Country Link
US (1) US4301250A (de)
EP (1) EP0028567B1 (de)
JP (1) JPS5679625A (de)
AT (1) ATE10806T1 (de)
DE (1) DE3069846D1 (de)
DK (1) DK462280A (de)
ES (1) ES496445A0 (de)
GR (1) GR70783B (de)
IE (1) IE50695B1 (de)
PT (1) PT71977B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE51173B1 (en) * 1980-03-27 1986-10-29 Merck & Co Inc Method of growing hepatitis b surface antigen
US4393133A (en) * 1980-06-12 1983-07-12 The Wistar Institute Of Anatomy And Biology Human hepatoma derived cell line, process for preparation thereof, and uses therefor
US4301249A (en) * 1980-07-23 1981-11-17 Merck & Co., Inc. High titer production of hepatitis A virus
US4416986A (en) * 1981-01-16 1983-11-22 Merck & Co., Inc. Methods of producing HBsAg
AU8746582A (en) * 1981-09-02 1983-03-10 Biogen N.V. Hepatitis b virus e type antigen
US4714613A (en) * 1982-09-30 1987-12-22 The Albert Einstein College Of Medicine Of Yeshiva University Method of suppressing cell growth by immunotherapy
GB8321789D0 (en) * 1983-08-12 1983-09-14 Biogen Nv Vaccines and compositions against hepatitis
JPS6078999A (ja) * 1983-10-05 1985-05-04 Chemo Sero Therapeut Res Inst ＨＢｓ抗原の精製方法
US5498537A (en) * 1994-03-09 1996-03-12 Cellco, Inc. Serum-free production of packaged viral vector
CN101688186A (zh) * 2007-05-04 2010-03-31 巴克斯特国际公司 用于病毒增殖的两阶段温度分布

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821087A (en) * 1972-05-18 1974-06-28 Dedrick R Cell culture on semi-permeable tubular membranes
JPS4940925A (de) * 1972-08-26 1974-04-17
JPS5531762B2 (de) * 1973-03-28 1980-08-20
JPS5127730A (de) * 1974-08-31 1976-03-08 Tokyo Shibaura Electric Co
JPS5822008B2 (ja) * 1975-08-07 1983-05-06 デユフアル・インテルナチオナル・レセ−ルフ・ベ−・ヴエ− 猫のヘルペスウイルスのワクチン
US4164566A (en) * 1978-08-17 1979-08-14 Merck & Co., Inc. Hepatitis a virus cell culture in vitro

Also Published As

Publication number Publication date
ES8202059A1 (es) 1982-01-16
PT71977A (en) 1980-11-01
DE3069846D1 (en) 1985-01-31
EP0028567A2 (de) 1981-05-13
PT71977B (en) 1982-03-31
ES496445A0 (es) 1982-01-16
GR70783B (de) 1983-03-23
IE50695B1 (en) 1986-06-25
DK462280A (da) 1981-05-03
JPS5679625A (en) 1981-06-30
US4301250A (en) 1981-11-17
EP0028567A3 (en) 1982-05-26
JPH0156051B2 (de) 1989-11-28
EP0028567B1 (de) 1984-12-19
IE802262L (en) 1981-05-02

Similar Documents

Publication Publication Date Title
ATE12255T1 (de) Verfahren zur herstellung von selbstreproduzierenden pankreatischen inseln aehnlichen strukturen von saeugetieren.
ATE6402T1 (de) Verfahren zur herstellung von hepatitis b oberflaechenantigen.
ES504199A0 (es) Un metodo para aumentar el rendimiento de vha en un cultivo celular in vitro
ATE10806T1 (de) Verfahren zur herstellung von hepatitis boberfl[chenantigen.
PT71739B (en) Process for preparing a cell culture of hepatitis a virus
PT72015A (en) Process for preparing in vitro culture of hepatitis b virus
JPS5650508A (en) Manufacture monocrystalling semiconductor substrate and its
ATE11568T1 (de) Verfahren zur herstellung von 11-alpha-hydroxy-20-alpha-hydroxymethyl-1,4-pre nadien-3-on.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time